Selected research
Industry Research
AI Tools for Cancer Therapy Industry Research Report 2026
Market perspective
The global AI Tools for Cancer Therapy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI Tools for Cancer Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI Tools for Cancer Therapy market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI Tools for Cancer Therapy market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI Tools for Cancer Therapy include Siemens Healthineers, GE Healthcare, ConcertAI, Medtronic, Roche, Oracle, NVIDIA, Philips and PathAI, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI Tools for Cancer Therapy market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI Tools for Cancer Therapy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI Tools for Cancer Therapy Market by Company
Siemens Healthineers
GE Healthcare
ConcertAI
Medtronic
Roche
Oracle
NVIDIA
Philips
PathAI
CureMetrix
Mindpeak
Paige AI
Predictive Oncology
Exscientia
Insilico Medicine
Iktos
Tempus
Azra AI
CureMatch
OncoLens
Triomics
Clinakos
Perthera
Cellworks Group
Biomy
AI Tools for Cancer Therapy Segment by Type
Solid Tumors
Hematological Malignancies
Others
AI Tools for Cancer Therapy Segment by Application
Hospitals
Pharmaceuticals
Research Institutes
Others
AI Tools for Cancer Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Tools for Cancer Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Tools for Cancer Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Tools for Cancer Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI Tools for Cancer Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global AI Tools for Cancer Therapy Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global AI Tools for Cancer Therapy Revenue Market Share by Type (2021-2026)
Table 7. Global AI Tools for Cancer Therapy Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global AI Tools for Cancer Therapy Revenue Market Share by Type (2027-2032)
Table 9. Global AI Tools for Cancer Therapy Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global AI Tools for Cancer Therapy Revenue Market Share by Application (2021-2026)
Table 11. Global AI Tools for Cancer Therapy Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global AI Tools for Cancer Therapy Revenue Market Share by Application (2027-2032)
Table 13. Global AI Tools for Cancer Therapy Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global AI Tools for Cancer Therapy Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global AI Tools for Cancer Therapy Market Share by Region (2021-2026)
Table 16. Global AI Tools for Cancer Therapy Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global AI Tools for Cancer Therapy Market Share by Region (2027-2032)
Table 18. AI Tools for Cancer Therapy Industry Trends
Table 19. AI Tools for Cancer Therapy Industry Drivers
Table 20. AI Tools for Cancer Therapy Industry Opportunities and Challenges
Table 21. AI Tools for Cancer Therapy Market Restraints
Table 22. Global Top AI Tools for Cancer Therapy Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global AI Tools for Cancer Therapy Revenue Market Share by Players (2021-2026)
Table 24. Global AI Tools for Cancer Therapy Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of AI Tools for Cancer Therapy, Headquarters and Area Served
Table 26. Global AI Tools for Cancer Therapy Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global AI Tools for Cancer Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America AI Tools for Cancer Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America AI Tools for Cancer Therapy Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America AI Tools for Cancer Therapy Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe AI Tools for Cancer Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe AI Tools for Cancer Therapy Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe AI Tools for Cancer Therapy Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific AI Tools for Cancer Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific AI Tools for Cancer Therapy Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific AI Tools for Cancer Therapy Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America AI Tools for Cancer Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America AI Tools for Cancer Therapy Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America AI Tools for Cancer Therapy Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa AI Tools for Cancer Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa AI Tools for Cancer Therapy Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa AI Tools for Cancer Therapy Market Size by Country (2027-2032) & (US$ Million)
Table 45. Siemens Healthineers Company Information
Table 46. Siemens Healthineers Business Overview
Table 47. Siemens Healthineers Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 48. Siemens Healthineers AI Tools for Cancer Therapy Product Portfolio
Table 49. Siemens Healthineers Recent Developments
Table 50. GE Healthcare Company Information
Table 51. GE Healthcare Business Overview
Table 52. GE Healthcare Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 53. GE Healthcare AI Tools for Cancer Therapy Product Portfolio
Table 54. GE Healthcare Recent Developments
Table 55. ConcertAI Company Information
Table 56. ConcertAI Business Overview
Table 57. ConcertAI Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 58. ConcertAI AI Tools for Cancer Therapy Product Portfolio
Table 59. ConcertAI Recent Developments
Table 60. Medtronic Company Information
Table 61. Medtronic Business Overview
Table 62. Medtronic Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 63. Medtronic AI Tools for Cancer Therapy Product Portfolio
Table 64. Medtronic Recent Developments
Table 65. Roche Company Information
Table 66. Roche Business Overview
Table 67. Roche Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 68. Roche AI Tools for Cancer Therapy Product Portfolio
Table 69. Roche Recent Developments
Table 70. Oracle Company Information
Table 71. Oracle Business Overview
Table 72. Oracle Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 73. Oracle AI Tools for Cancer Therapy Product Portfolio
Table 74. Oracle Recent Developments
Table 75. NVIDIA Company Information
Table 76. NVIDIA Business Overview
Table 77. NVIDIA Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 78. NVIDIA AI Tools for Cancer Therapy Product Portfolio
Table 79. NVIDIA Recent Developments
Table 80. Philips Company Information
Table 81. Philips Business Overview
Table 82. Philips Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 83. Philips AI Tools for Cancer Therapy Product Portfolio
Table 84. Philips Recent Developments
Table 85. PathAI Company Information
Table 86. PathAI Business Overview
Table 87. PathAI Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 88. PathAI AI Tools for Cancer Therapy Product Portfolio
Table 89. PathAI Recent Developments
Table 90. CureMetrix Company Information
Table 91. CureMetrix Business Overview
Table 92. CureMetrix Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 93. CureMetrix AI Tools for Cancer Therapy Product Portfolio
Table 94. CureMetrix Recent Developments
Table 95. Mindpeak Company Information
Table 96. Mindpeak Business Overview
Table 97. Mindpeak Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 98. Mindpeak AI Tools for Cancer Therapy Product Portfolio
Table 99. Mindpeak Recent Developments
Table 100. Paige AI Company Information
Table 101. Paige AI Business Overview
Table 102. Paige AI Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 103. Paige AI AI Tools for Cancer Therapy Product Portfolio
Table 104. Paige AI Recent Developments
Table 105. Predictive Oncology Company Information
Table 106. Predictive Oncology Business Overview
Table 107. Predictive Oncology Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 108. Predictive Oncology AI Tools for Cancer Therapy Product Portfolio
Table 109. Predictive Oncology Recent Developments
Table 110. Exscientia Company Information
Table 111. Exscientia Business Overview
Table 112. Exscientia Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 113. Exscientia AI Tools for Cancer Therapy Product Portfolio
Table 114. Exscientia Recent Developments
Table 115. Insilico Medicine Company Information
Table 116. Insilico Medicine Business Overview
Table 117. Insilico Medicine Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 118. Insilico Medicine AI Tools for Cancer Therapy Product Portfolio
Table 119. Insilico Medicine Recent Developments
Table 120. Iktos Company Information
Table 121. Iktos Business Overview
Table 122. Iktos Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 123. Iktos AI Tools for Cancer Therapy Product Portfolio
Table 124. Iktos Recent Developments
Table 125. Tempus Company Information
Table 126. Tempus Business Overview
Table 127. Tempus Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 128. Tempus AI Tools for Cancer Therapy Product Portfolio
Table 129. Tempus Recent Developments
Table 130. Azra AI Company Information
Table 131. Azra AI Business Overview
Table 132. Azra AI Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 133. Azra AI AI Tools for Cancer Therapy Product Portfolio
Table 134. Azra AI Recent Developments
Table 135. CureMatch Company Information
Table 136. CureMatch Business Overview
Table 137. CureMatch Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 138. CureMatch AI Tools for Cancer Therapy Product Portfolio
Table 139. CureMatch Recent Developments
Table 140. OncoLens Company Information
Table 141. OncoLens Business Overview
Table 142. OncoLens Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 143. OncoLens AI Tools for Cancer Therapy Product Portfolio
Table 144. OncoLens Recent Developments
Table 145. Triomics Company Information
Table 146. Triomics Business Overview
Table 147. Triomics Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 148. Triomics AI Tools for Cancer Therapy Product Portfolio
Table 149. Triomics Recent Developments
Table 150. Clinakos Company Information
Table 151. Clinakos Business Overview
Table 152. Clinakos Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 153. Clinakos AI Tools for Cancer Therapy Product Portfolio
Table 154. Clinakos Recent Developments
Table 155. Perthera Company Information
Table 156. Perthera Business Overview
Table 157. Perthera Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 158. Perthera AI Tools for Cancer Therapy Product Portfolio
Table 159. Perthera Recent Developments
Table 160. Cellworks Group Company Information
Table 161. Cellworks Group Business Overview
Table 162. Cellworks Group Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 163. Cellworks Group AI Tools for Cancer Therapy Product Portfolio
Table 164. Cellworks Group Recent Developments
Table 165. Biomy Company Information
Table 166. Biomy Business Overview
Table 167. Biomy Revenue in AI Tools for Cancer Therapy Business (2021-2026) & (US$ Million)
Table 168. Biomy AI Tools for Cancer Therapy Product Portfolio
Table 169. Biomy Recent Developments
Table 170. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. AI Tools for Cancer Therapy Product Image
Figure 5. Global AI Tools for Cancer Therapy Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global AI Tools for Cancer Therapy Market Share by Type: 2025 VS 2032
Figure 7. Solid Tumors Product
Figure 8. Hematological Malignancies Product
Figure 9. Others Product
Figure 10. Global AI Tools for Cancer Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global AI Tools for Cancer Therapy Market Share by Application: 2025 VS 2032
Figure 12. Hospitals Product
Figure 13. Pharmaceuticals Product
Figure 14. Research Institutes Product
Figure 15. Others Product
Figure 16. Global AI Tools for Cancer Therapy Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 17. Global AI Tools for Cancer Therapy Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global AI Tools for Cancer Therapy Market Share by Region: 2025 VS 2032
Figure 19. Global AI Tools for Cancer Therapy Market Share by Players in 2025
Figure 20. Global AI Tools for Cancer Therapy Manufacturers Established Date
Figure 21. Global Top 5 and 10 AI Tools for Cancer Therapy Players Market Share by Revenue in 2025
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. North America AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. North America AI Tools for Cancer Therapy Market Share by Country (2021-2032)
Figure 25. United States AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Canada AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Mexico AI Tools for Cancer Therapy Market Share by Country (2021-2032)
Figure 28. Europe AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Europe AI Tools for Cancer Therapy Market Share by Country (2021-2032)
Figure 30. Germany AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. France AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. U.K. AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Italy AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Spain AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Russia AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Netherlands AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Nordic Countries AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific AI Tools for Cancer Therapy Market Share by Country (2021-2032)
Figure 40. China AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Japan AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. South Korea AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India AI Tools for Cancer Therapy Market Share by Country (2021-2032)
Figure 45. Australia AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. China Taiwan AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. Southeast Asia AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America AI Tools for Cancer Therapy Market Share by Country (2021-2032)
Figure 50. Brazil AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Argentina AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Chile AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Colombia AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Peru AI Tools for Cancer Therapy Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Siemens Healthineers Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 56. GE Healthcare Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 57. ConcertAI Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 58. Medtronic Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 59. Roche Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 60. Oracle Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 61. NVIDIA Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 62. Philips Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 63. PathAI Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 64. CureMetrix Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 65. Mindpeak Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 66. Paige AI Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 67. Predictive Oncology Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 68. Exscientia Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 69. Insilico Medicine Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 70. Iktos Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 71. Tempus Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 72. Azra AI Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 73. CureMatch Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 74. OncoLens Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 75. Triomics Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 76. Clinakos Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 77. Perthera Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 78. Cellworks Group Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Figure 79. Biomy Revenue Growth Rate in AI Tools for Cancer Therapy Business (2021-2026)
Scope & coverage.
Types
- Solid Tumors
- Hematological Malignancies
- Others
Applications
- Hospitals
- Pharmaceuticals
- Research Institutes
- Others
Companies covered
- Siemens Healthineers
- GE Healthcare
- ConcertAI
- Medtronic
- Roche
- Oracle
- NVIDIA
- Philips
- PathAI
- CureMetrix
- Mindpeak
- Paige AI
- Predictive Oncology
- Exscientia
- Insilico Medicine
- Iktos
- Tempus
- Azra AI
- CureMatch
- OncoLens
- Triomics
- Clinakos
- Perthera
- Cellworks Group
- Biomy
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI Tools for Cancer Therapy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Solid Tumors
- 2.2.3 Hematological Malignancies
- 2.2.4 Others
- 2.3 AI Tools for Cancer Therapy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Pharmaceuticals
- 2.3.4 Research Institutes
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 AI Tools for Cancer Therapy Breakdown Data by Type
- 3.1 Global AI Tools for Cancer Therapy Historic Market Size by Type (2021-2026)
- 3.2 Global AI Tools for Cancer Therapy Forecasted Market Size by Type (2027-2032)
4 AI Tools for Cancer Therapy Breakdown Data by Application
- 4.1 Global AI Tools for Cancer Therapy Historic Market Size by Application (2021-2026)
- 4.2 Global AI Tools for Cancer Therapy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI Tools for Cancer Therapy Market Perspective (2021-2032)
- 5.2 Global AI Tools for Cancer Therapy Growth Trends by Region
- 5.2.1 Global AI Tools for Cancer Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI Tools for Cancer Therapy Historic Market Size by Region (2021-2026)
- 5.2.3 AI Tools for Cancer Therapy Forecasted Market Size by Region (2027-2032)
- 5.3 AI Tools for Cancer Therapy Market Dynamics
- 5.3.1 AI Tools for Cancer Therapy Industry Trends
- 5.3.2 AI Tools for Cancer Therapy Market Drivers
- 5.3.3 AI Tools for Cancer Therapy Market Challenges
- 5.3.4 AI Tools for Cancer Therapy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI Tools for Cancer Therapy Players by Revenue
- 6.1.1 Global Top AI Tools for Cancer Therapy Players by Revenue (2021-2026)
- 6.1.2 Global AI Tools for Cancer Therapy Revenue Market Share by Players (2021-2026)
- 6.2 Global AI Tools for Cancer Therapy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI Tools for Cancer Therapy Head Office and Area Served
- 6.4 Global AI Tools for Cancer Therapy Players, Product Type & Application
- 6.5 Global AI Tools for Cancer Therapy Manufacturers Established Date
- 6.6 Global AI Tools for Cancer Therapy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI Tools for Cancer Therapy Market Size (2021-2032)
- 7.2 North America AI Tools for Cancer Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI Tools for Cancer Therapy Market Size by Country (2021-2026)
- 7.4 North America AI Tools for Cancer Therapy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI Tools for Cancer Therapy Market Size (2021-2032)
- 8.2 Europe AI Tools for Cancer Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI Tools for Cancer Therapy Market Size by Country (2021-2026)
- 8.4 Europe AI Tools for Cancer Therapy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI Tools for Cancer Therapy Market Size (2021-2032)
- 9.2 Asia-Pacific AI Tools for Cancer Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI Tools for Cancer Therapy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI Tools for Cancer Therapy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI Tools for Cancer Therapy Market Size (2021-2032)
- 10.2 South America AI Tools for Cancer Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI Tools for Cancer Therapy Market Size by Country (2021-2026)
- 10.4 South America AI Tools for Cancer Therapy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI Tools for Cancer Therapy Market Size (2021-2032)
- 11.2 Middle East & Africa AI Tools for Cancer Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI Tools for Cancer Therapy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI Tools for Cancer Therapy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Siemens Healthineers
- 12.1.1 Siemens Healthineers Company Information
- 12.1.2 Siemens Healthineers Business Overview
- 12.1.3 Siemens Healthineers Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.1.4 Siemens Healthineers AI Tools for Cancer Therapy Product Portfolio
- 12.1.5 Siemens Healthineers Recent Developments
- 12.2 GE Healthcare
- 12.2.1 GE Healthcare Company Information
- 12.2.2 GE Healthcare Business Overview
- 12.2.3 GE Healthcare Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.2.4 GE Healthcare AI Tools for Cancer Therapy Product Portfolio
- 12.2.5 GE Healthcare Recent Developments
- 12.3 ConcertAI
- 12.3.1 ConcertAI Company Information
- 12.3.2 ConcertAI Business Overview
- 12.3.3 ConcertAI Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.3.4 ConcertAI AI Tools for Cancer Therapy Product Portfolio
- 12.3.5 ConcertAI Recent Developments
- 12.4 Medtronic
- 12.4.1 Medtronic Company Information
- 12.4.2 Medtronic Business Overview
- 12.4.3 Medtronic Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.4.4 Medtronic AI Tools for Cancer Therapy Product Portfolio
- 12.4.5 Medtronic Recent Developments
- 12.5 Roche
- 12.5.1 Roche Company Information
- 12.5.2 Roche Business Overview
- 12.5.3 Roche Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.5.4 Roche AI Tools for Cancer Therapy Product Portfolio
- 12.5.5 Roche Recent Developments
- 12.6 Oracle
- 12.6.1 Oracle Company Information
- 12.6.2 Oracle Business Overview
- 12.6.3 Oracle Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.6.4 Oracle AI Tools for Cancer Therapy Product Portfolio
- 12.6.5 Oracle Recent Developments
- 12.7 NVIDIA
- 12.7.1 NVIDIA Company Information
- 12.7.2 NVIDIA Business Overview
- 12.7.3 NVIDIA Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.7.4 NVIDIA AI Tools for Cancer Therapy Product Portfolio
- 12.7.5 NVIDIA Recent Developments
- 12.8 Philips
- 12.8.1 Philips Company Information
- 12.8.2 Philips Business Overview
- 12.8.3 Philips Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.8.4 Philips AI Tools for Cancer Therapy Product Portfolio
- 12.8.5 Philips Recent Developments
- 12.9 PathAI
- 12.9.1 PathAI Company Information
- 12.9.2 PathAI Business Overview
- 12.9.3 PathAI Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.9.4 PathAI AI Tools for Cancer Therapy Product Portfolio
- 12.9.5 PathAI Recent Developments
- 12.10 CureMetrix
- 12.10.1 CureMetrix Company Information
- 12.10.2 CureMetrix Business Overview
- 12.10.3 CureMetrix Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.10.4 CureMetrix AI Tools for Cancer Therapy Product Portfolio
- 12.10.5 CureMetrix Recent Developments
- 12.11 Mindpeak
- 12.11.1 Mindpeak Company Information
- 12.11.2 Mindpeak Business Overview
- 12.11.3 Mindpeak Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.11.4 Mindpeak AI Tools for Cancer Therapy Product Portfolio
- 12.11.5 Mindpeak Recent Developments
- 12.12 Paige AI
- 12.12.1 Paige AI Company Information
- 12.12.2 Paige AI Business Overview
- 12.12.3 Paige AI Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.12.4 Paige AI AI Tools for Cancer Therapy Product Portfolio
- 12.12.5 Paige AI Recent Developments
- 12.13 Predictive Oncology
- 12.13.1 Predictive Oncology Company Information
- 12.13.2 Predictive Oncology Business Overview
- 12.13.3 Predictive Oncology Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.13.4 Predictive Oncology AI Tools for Cancer Therapy Product Portfolio
- 12.13.5 Predictive Oncology Recent Developments
- 12.14 Exscientia
- 12.14.1 Exscientia Company Information
- 12.14.2 Exscientia Business Overview
- 12.14.3 Exscientia Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.14.4 Exscientia AI Tools for Cancer Therapy Product Portfolio
- 12.14.5 Exscientia Recent Developments
- 12.15 Insilico Medicine
- 12.15.1 Insilico Medicine Company Information
- 12.15.2 Insilico Medicine Business Overview
- 12.15.3 Insilico Medicine Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.15.4 Insilico Medicine AI Tools for Cancer Therapy Product Portfolio
- 12.15.5 Insilico Medicine Recent Developments
- 12.16 Iktos
- 12.16.1 Iktos Company Information
- 12.16.2 Iktos Business Overview
- 12.16.3 Iktos Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.16.4 Iktos AI Tools for Cancer Therapy Product Portfolio
- 12.16.5 Iktos Recent Developments
- 12.17 Tempus
- 12.17.1 Tempus Company Information
- 12.17.2 Tempus Business Overview
- 12.17.3 Tempus Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.17.4 Tempus AI Tools for Cancer Therapy Product Portfolio
- 12.17.5 Tempus Recent Developments
- 12.18 Azra AI
- 12.18.1 Azra AI Company Information
- 12.18.2 Azra AI Business Overview
- 12.18.3 Azra AI Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.18.4 Azra AI AI Tools for Cancer Therapy Product Portfolio
- 12.18.5 Azra AI Recent Developments
- 12.19 CureMatch
- 12.19.1 CureMatch Company Information
- 12.19.2 CureMatch Business Overview
- 12.19.3 CureMatch Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.19.4 CureMatch AI Tools for Cancer Therapy Product Portfolio
- 12.19.5 CureMatch Recent Developments
- 12.20 OncoLens
- 12.20.1 OncoLens Company Information
- 12.20.2 OncoLens Business Overview
- 12.20.3 OncoLens Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.20.4 OncoLens AI Tools for Cancer Therapy Product Portfolio
- 12.20.5 OncoLens Recent Developments
- 12.21 Triomics
- 12.21.1 Triomics Company Information
- 12.21.2 Triomics Business Overview
- 12.21.3 Triomics Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.21.4 Triomics AI Tools for Cancer Therapy Product Portfolio
- 12.21.5 Triomics Recent Developments
- 12.22 Clinakos
- 12.22.1 Clinakos Company Information
- 12.22.2 Clinakos Business Overview
- 12.22.3 Clinakos Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.22.4 Clinakos AI Tools for Cancer Therapy Product Portfolio
- 12.22.5 Clinakos Recent Developments
- 12.23 Perthera
- 12.23.1 Perthera Company Information
- 12.23.2 Perthera Business Overview
- 12.23.3 Perthera Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.23.4 Perthera AI Tools for Cancer Therapy Product Portfolio
- 12.23.5 Perthera Recent Developments
- 12.24 Cellworks Group
- 12.24.1 Cellworks Group Company Information
- 12.24.2 Cellworks Group Business Overview
- 12.24.3 Cellworks Group Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.24.4 Cellworks Group AI Tools for Cancer Therapy Product Portfolio
- 12.24.5 Cellworks Group Recent Developments
- 12.25 Biomy
- 12.25.1 Biomy Company Information
- 12.25.2 Biomy Business Overview
- 12.25.3 Biomy Revenue in AI Tools for Cancer Therapy Business (2021-2026)
- 12.25.4 Biomy AI Tools for Cancer Therapy Product Portfolio
- 12.25.5 Biomy Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst